Could anybody comment on any latest development in area of patience diaries
and clinical trials, 
in other words, there are obvious ambiguities in terms of the need for
disclosures authorizations and general information protection during dairies
review process and so on, 
Any comments are welcome

Jacob Vishnevsky
Stelex-TVG 
Two Greenwood Square, Suite 310 
3331 Street Road 
Bensalem, PA 19020 
phone: (215) 352-1133
cell:(215) 421-8539 
fax: (215) 638-9333 
email: [EMAIL PROTECTED] <mailto:[EMAIL PROTECTED]> 



-----Original Message-----
From: Angie Lehman [mailto:[EMAIL PROTECTED]]
Sent: Monday, July 15, 2002 4:26 PM
To: '[EMAIL PROTECTED]'
Subject: RE: please remove me from your listserv 



Thank you

The WEDI SNIP listserv to which you are subscribed is not moderated.  The
discussions on this listserv therefore represent the views of the individual
participants, and do not necessarily represent the views of the WEDI Board
of
Directors nor WEDI SNIP.  If you wish to receive an official opinion, post
your question to the WEDI SNIP Issues Database at
http://snip.wedi.org/tracking/.
Posting of advertisements or other commercial use of this listserv is
specifically prohibited.

The WEDI SNIP listserv to which you are subscribed is not moderated.  The
discussions on this listserv therefore represent the views of the individual
participants, and do not necessarily represent the views of the WEDI Board
of
Directors nor WEDI SNIP.  If you wish to receive an official opinion, post
your question to the WEDI SNIP Issues Database at
http://snip.wedi.org/tracking/.
Posting of advertisements or other commercial use of this listserv is
specifically prohibited.


The WEDI SNIP listserv to which you are subscribed is not moderated.  The
discussions on this listserv therefore represent the views of the individual
participants, and do not necessarily represent the views of the WEDI Board of
Directors nor WEDI SNIP.  If you wish to receive an official opinion, post
your question to the WEDI SNIP Issues Database at
http://snip.wedi.org/tracking/.
Posting of advertisements or other commercial use of this listserv is
specifically prohibited.

Reply via email to